Immune modulation for cancer therapy

por Naidoo, J, Page, D B, Wolchok, J D
Publicado 2014

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

por Hamid, O, Robert, C, Daud, A, Hodi, F S, Hwu, W J, Kefford, R, Wolchok, J D, Hersey, P, Joseph, R, Weber, J S, Dronca, R, Mitchell, T C, Patnaik, A, Zarour, H M, Joshua, A M, Zhao, Q, Jensen, E, Ahsan, S, Ibrahim, N, Ribas, A
Publicado 2019